Result from 5 years follow-up on ovarian cancer patients

This is a comparison between two groups of ovarian cancer patients. Patients in control group receive treatment with regular methods. Patients in comparison group receive the regular treatment methods and the DC-CIK cancer immunotherapy.

Ovarian Cancer

Each patient was followed for five years, and it came up with the list as below, it shows that patients who received cancer immunotherapy had more chances of cancer survival or cancer free rate.

Share this article

Effective and affordable immunotherapy and CAR T-cell Therapy?

Contact us and get detailed information about getting advanced immunotherapy and CAR T-cell therapy for the treatment of solid tumors, blood cancers and HPV infection.